These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 16799333

  • 21. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.
    Teitz-Tennenbaum S, Li Q, Rynkiewicz S, Ito F, Davis MA, McGinn CJ, Chang AE.
    Cancer Res; 2003 Dec 01; 63(23):8466-75. PubMed ID: 14679011
    [Abstract] [Full Text] [Related]

  • 22. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
    Schreurs MW, Eggert AA, de Boer AJ, Vissers JL, van Hall T, Offringa R, Figdor CG, Adema GJ.
    Cancer Res; 2000 Dec 15; 60(24):6995-7001. PubMed ID: 11156402
    [Abstract] [Full Text] [Related]

  • 23. Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy.
    VanOosten RL, Griffith TS.
    Cancer Res; 2007 Dec 15; 67(24):11980-90. PubMed ID: 18089829
    [Abstract] [Full Text] [Related]

  • 24. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
    Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD.
    Cancer Res; 2004 Aug 01; 64(15):5407-14. PubMed ID: 15289349
    [Abstract] [Full Text] [Related]

  • 25. Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis.
    Agallou M, Margaroni M, Karagouni E.
    Vaccine; 2011 Jul 12; 29(31):5053-64. PubMed ID: 21569815
    [Abstract] [Full Text] [Related]

  • 26. CpG oligonucleotide as an adjuvant for the treatment of prostate cancer.
    Lubaroff DM, Karan D.
    Adv Drug Deliv Rev; 2009 Mar 28; 61(3):268-74. PubMed ID: 19166887
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A, Chatterjee SK, Foon KA, Celis E, Bhattacharya-Chatterjee M.
    Cancer Res; 2007 Mar 15; 67(6):2881-92. PubMed ID: 17363612
    [Abstract] [Full Text] [Related]

  • 31. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine.
    den Brok MH, Sutmuller RP, Nierkens S, Bennink EJ, Toonen LW, Figdor CG, Ruers TJ, Adema GJ.
    Cancer Res; 2006 Jul 15; 66(14):7285-92. PubMed ID: 16849578
    [Abstract] [Full Text] [Related]

  • 32. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
    You J, Wang CL, Hao XS.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2785-90. PubMed ID: 18167273
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism.
    Steitz J, Brück J, Knop J, Tüting T.
    Gene Ther; 2001 Aug 23; 8(16):1255-63. PubMed ID: 11509959
    [Abstract] [Full Text] [Related]

  • 36. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T, Kamigaki T, Nakamura T, Imanishi T, Hayashi S, Kawasaki K, Takase S, Ajiki T, Kuroda Y.
    Oncol Rep; 2006 Dec 23; 16(6):1317-24. PubMed ID: 17089056
    [Abstract] [Full Text] [Related]

  • 37. Impaired lung dendritic cell migration and T cell stimulation induced by immunostimulatory oligonucleotides contribute to reduced allergic airway inflammation.
    Constabel H, Stankov MV, Hartwig C, Tschernig T, Behrens GM.
    J Immunol; 2009 Sep 01; 183(5):3443-53. PubMed ID: 19667097
    [Abstract] [Full Text] [Related]

  • 38. Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy.
    Boczkowski D, Lee J, Pruitt S, Nair S.
    Cancer Gene Ther; 2009 Dec 01; 16(12):900-11. PubMed ID: 19498460
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.